Our Research Team utilizes a wide range of expertise to conduct innovative research at an unprecedented scale and level of complexity. Each of the groups below plays an essential role in supporting our mission of making new genetic discoveries possible.

Genomics R&D

Made up of computational biologists, statistical geneticists, and bioinformaticians, this group is responsible for maintaining and improving our core methods for making genetic discoveries. These methods are the basis for all scientific efforts across the company, from supporting new features in our product to identifying drug target candidates for our Therapeutics division. Our statistical expertise, combined with what is one of the largest genomic datasets in the world, has made 23andMe a leader in studying human traits and diseases.

Read More | Meet the Team

  • Joyce Tung

  • David Hinds

  • Adam Auton

  • Chao Tian

  • Robert Bell

  • Aaron Kleinman

  • Pierre Fontanillas

  • Suyash S. Shringarpure

  • Xin Wang

  • Sahar Mozaffari

  • Keng-Han Lin

  • Yunxuan Jiang

  • Briana Cameron

  • Priyanka Nandakumar

  • Jing Shi

  • Wei Wang

  • Karl Heilbron

  • Barry Hicks

  • Yunru (Claire) Huang

  • Sayantan Das

  • Teresa Filshtein Sonmez

Ancestry R&D

Our Ancestry R&D Team develops algorithms and reference datasets that support all aspects of our Ancestry Service, including our Ancestry Composition and DNA Relatives features. Our population geneticists developed a pioneering local ancestry inference algorithm known as Ancestry Painting, and a decade later, more recent versions of this algorithm continue to distinguish our Ancestry Service from those of our competitors. We also created DNA Relatives (formerly known as Relative Finder), the first algorithm for identifying relatives within a large genetic database.

Read More | Meet the Team

  • Joanna Mountain

  • Kasia Bryc

  • G. David Poznik

  • Kimberly McManus

  • Samarth Rangavittal

  • Will Freyman

  • Steven Micheletti

  • Ethan Jewett

Health R&D

How can we leverage our unique dataset to revolutionize health and wellness? Our Health R&D Team is always on the lookout for new ways to develop data-driven health products that improve the wellbeing of our customers. Our Genetic Weight report, launched in 2017, was the first Wellness report based on data from 23andMe research participants rather than published literature. Since then we have continued to utilize the latest machine learning algorithms to produce robust risk prediction models, that combine genetics with lifestyle and environment to predict important health outcomes. We work closely with our Product Science team to figure out how to implement these algorithms in our product.

Read More | Meet the Team

  • Geoff Benton

  • Nick Furlotte

  • Mike Macpherson

  • Sarah Laskey

  • Nick Eriksson

  • Peter Chisnell

  • Rafaela Bagur Quetglas

Data Collection

Genetic discoveries are not possible without phenotypic data. Our one billion data points, gathered through self-report surveys, cover a wide range of topics, from wellness and behavior, to diseases or chronic conditions. The topics of these questionnaires cover conditions that are both serious, such as cancer, and not so serious, like acne. We also ask about common conditions like heart disease, as well as rare ones like ALS. Our Data Collection Team utilizes a breadth of essential expertise — including public health, epidemiology, biostatistics, social sciences, and psychology — to ensure the quality of our phenotypic data and to support scientific endeavors across the Research Team.

Read MoreMeet the Team

  • Matthew McIntyre

  • Janie Shelton

  • Stella Aslibekyan

  • Liz Babalola

  • Devika Dhamija

  • Yunru (Claire) Huang

  • Catherine Weldon

  • Daniella Coker

  • Lindsey Tran

Research Ethics & Policy

Respecting our research participants is our highest priority. Our Research Ethics and Policy Team addresses a range of issues connected to our ground-breaking research program, including informed consent, recruitment, privacy, and data sharing and management. Over 80% of our customers provide consent to participate in research, and we evaluate new forms of research recruitment based on genetic and phenotype data, focusing on proper handling of potentially sensitive data and ensuring that research participation minimizes harm and maximizes potential benefits. We also enact policies around data handling and sharing that are designed to maximize the impact of our massive research database while ensuring the privacy of our research participants. 

Read More | Meet the Team

  • Sarah Elson

  • Michelle Agee

  • Pooja Gandhi

  • Sarah Clark

  • Emily Bullis

  • Johnathan Bowes

  • Trung Le

Project Management & Operations

At 23andMe, we are redefining the field of human genetics by conducting research studies at an unprecedented scale and level of complexity. We are always dreaming up new ways to innovate, such as enabling people to participate in studies from the convenience of their phones, asking research participants to self-administer a well-established pain endurance test, and recruiting tens of thousands of research participants at breakneck speeds. These projects involve teams from across 23andMe and sometimes involve academic collaborators, industry partners, and non-profit and government funding agencies.

Read MoreMeet the Team

  • Carrie Northover

  • Anna Faaborg

  • Paul Cannon

  • Shirin Fuller

  • Liz Noblin

  • Helen Rowbotham

  • Meghan Moreno

  • Jennifer McCreight

  • Anjali Shastri

  • Rose Eckert

  • Amir Zare

  • Madeleine Schloetter

  • Alexandra Langston

  • Marie Luff

  • Vanessa Lane

  • Aaron Petrakovitz

  • Chelsea Ye

  • Leah Slang

  • Eli Chanoff

  • Katelyn Kukar

  • Eric Lowe

  • Vikram Satyan

  • Morgan Schumacher

Our Commitment to Unbiased Research

23andMe is committed to promoting objectivity and eliminating bias in our research.
Read about our policy to prevent financial conflicts of interests.